Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Changing Column Packing from an Art into a Science
Navigating Technology Transfer
Enabling Total Biopharma Solutions
Pall Life Sciences
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
View All Featured ArticlesHeadline News
Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial
Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis
Roche receives CE Mark for compact cobas smart e immunoanalyser
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
BPOG Risk Based Approaches to Use of Closed Systems in Renovations of Existing Biopharma API Facilities
Presented by Lars Hovmand-Lyster, Senior Engineering specialist in Novo Nordisk Global Project Office (GPO) Engineering management department and Ernest Jenness, Senior Product Manager for Mobius Single-Use Products at Merck
05th March 2019
Process Analytical Technologies – Advances in Bioprocess Integration to Transition to Digital Manufacturing
Presented by Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur and Gabriella Gerzon, PhD Candidate, York University, Toronto, Canada, and Martin Gadsby, Vice President , Optimal Industrial Technologies Ltd
25th January 2023
New Drying Processes for Biopharmaceuticals
Presented by Sune Klint Andersen, Principal Scientist at Janssen Pharmaceutical Companies of Johnson & Johnson and Lars Markwort co-founder and CEO of Bioinicia SL
05th May 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Best Practices for Achieving Virus Safety
Strategy Emerging Markets for Risk Mitigation
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
